Mekinist
Payments companies reported to CMS as associated with Mekinist. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mekinist, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mekinist
These are the largest totals companies reported as associated with Mekinist. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Andrea Ventola | Florham Park, NJ | Obstetrics & Gynecology (Nurse Practitioner) | $66,874.98 |
| Wendy Hein | Kansas City, KS | Pediatrics (Nurse Practitioner) | $66,131.93 |
| Lori Wirth | Boston, MA | Medical Oncology | $16,275.11 |
| Steven Sherman | Houston, TX | Endocrinology, Diabetes & Metabolism | $10,869.42 |
| Rimas Lukas | Chicago, IL | Hematology & Oncology | $9,133.95 |
| Adil Daud | Tampa, FL | Medical Oncology | $8,739.96 |
| Vivek Subbiah | Houston, TX | Pediatric Hematology-Oncology | $7,575.00 |
| Jochen Lorch | Chicago, IL | Hematology & Oncology | $7,102.12 |
| Hussein Tawbi | Houston, TX | Internal Medicine | $5,364.72 |
| Sapna Patel | Aurora, CO | Medical Oncology | $4,875.00 |
Prescribed Mekinist?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.